LATEST News

After COVID-19 outbreak, rapid action is needed to develop solutions for testing a pathogen never seen before.

As a life science company, Cyanagen wants to offer its contribution in response to COVID-19, providing for its extensive portfolio of chemiluminescence and fluorescent detection reagents that could be useful in the development of several diagnostic solutions.

We will be proud to help researchers and companies around the world to support their efforts in fighting this outbreak.

Its extreme sensitivity and extraordinary light output allow the detection of trace amounts of proteins. The formulation provides a low background for an extremely high signal to noise ratio.